Sagar V. Parikh, M.D.
Sagar V. Parikh, M.D., is the John F. Greden Professor of Depression and Clinical Neuroscience at the University of Michigan and associate director of the University of Michigan Comprehensive Depression Center. He is also a professor of health management and policy at the School of Public Health.
Previously, he was professor of psychiatry at the University of Toronto, where he had been director of continuing mental health education and head of general psychiatry.
At Toronto’s major hospital grouping, the University Health Network, Dr. Parikh completed two terms as deputy psychiatrist in chief and was president of the medical staff association. Before that he was head of the bipolar clinic and director of continuing medical education at the Centre for Addiction and Mental Health.
Dr. Parikh is the author/editor of two books and more than 130 peer-reviewed articles and book chapters, and co-author of the Canadian Network for Mood and Anxiety Treatments guidelines for depression and for bipolar disorder. He has conducted clinical trials examining the combination of medication and psychotherapy for bipolar disorder and for depression, as well as pharmacotherapy trials in mood disorders. As medical director of the Mensante Corp. in Toronto, he helped create a novel Internet system for the recognition and management of mental disorders.
Dr. Parikh is medical director of the National Network of Depression Centers (USA), serves as secretary of the International Society of Affective Disorders, and is co-head of the section of affective disorders of the World Psychiatric Association. He has received a number of awards for his teaching, most recently the Association of Chairs of Psychiatry Award for Excellence in Education.
Latest by Sagar V. Parikh, M.D.
Depression and anxiety affect not only the mind but also the whole body, including the digestive system and the heart. Here’s what to know.
Everyone worries, to some degree, about things at work or home. And with news of violent incidents and uncertainty about the economy, who doesn’t consider worst-case scenarios? Almost everyone seems to experience worrisome thoughts. So how do you kno...
Research shows cognitive behavioral therapy may relieve anxiety by changing the physical structure of the amygdala, the part of the brain linked to fear.
Letting people with obsessive-compulsive disorder decide when to give up “safety behaviors” may be more effective than letting a therapist make the decision.
The prevalence of anxiety disorders varies among people of different ages, backgrounds, and nationalities. Who is at highest risk?
If you take antidepressants to help relieve symptoms of depression, certain nutraceuticals may help your medications work more effectively.
Combining meditation and moderate-intensity aerobic exercise can significantly reduce symptoms of depression, research shows.
Approximately two of every five people who are depressed later go on to become happy or satisfied with their lives most of the time, according to new research.
The risk of self-injury and suicide is high in people with bipolar disorder. Lithium can help.
The FDA has changed the brand name of an antidepressant to avoid confusion with a blood-thinning medication.